Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges
ABSTRACT Increasing incidences of multidrug resistance in pathogenic bacteria threaten our ability to treat and manage bacterial infection. The development and FDA approval of novel antibiotics have slowed over the past decade; therefore, the adoption and improvement of alternative therapeutic strat...
Guardado en:
Autores principales: | Chih-Yuan Chiang, Ijeoma Uzoma, Richard T. Moore, Merle Gilbert, Allen J. Duplantier, Rekha G. Panchal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7de0eec81d1e40dc8ff6383e4cf2aa95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment-Resistant Bacterial Keratitis: Challenges and Solutions
por: Egrilmez S, et al.
Publicado: (2020) -
Multiple antibiotic susceptibility of polyphosphate kinase mutants (ppk1 and ppk2) from Pseudomonas aeruginosa PAO1 as revealed by global phenotypic analysis
por: Ortiz-Severín,Javiera, et al.
Publicado: (2015) -
Combating Drug-Resistant Bacteria Using Photothermally Active Nanomaterials: A Perspective Review
por: Kawaljeet Kaur, et al.
Publicado: (2021) -
Metformin as a Potential Adjuvant Antimicrobial Agent Against Multidrug Resistant Bacteria
por: Masadeh MM, et al.
Publicado: (2021) -
Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis
por: Hye-Ra Lee, et al.
Publicado: (2020)